 | • レポートコード：MRC2-11QY12201 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はHIV診断のグローバル市場について調査・分析したレポートです。種類別（消耗品、アッセイ・キット・試薬、その他消耗品、機器、ソフトウェア・サービス）市場規模、用途別（抗体検査、ウイルス量検査、CD4検査、乳幼児早期診断検査、ウイルス同定検査）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別HIV診断の競争状況、市場シェア ・世界のHIV診断市場：種類別市場規模 2015年-2020年（消耗品、アッセイ・キット・試薬、その他消耗品、機器、ソフトウェア・サービス） ・世界のHIV診断市場：種類別市場規模予測 2021年-2026年（消耗品、アッセイ・キット・試薬、その他消耗品、機器、ソフトウェア・サービス） ・世界のHIV診断市場：用途別市場規模 2015年-2020年（抗体検査、ウイルス量検査、CD4検査、乳幼児早期診断検査、ウイルス同定検査） ・世界のHIV診断市場：用途別市場規模予測 2021年-2026年（抗体検査、ウイルス量検査、CD4検査、乳幼児早期診断検査、ウイルス同定検査） ・北米のHIV診断市場分析：米国、カナダ ・ヨーロッパのHIV診断市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのHIV診断市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のHIV診断市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのHIV診断市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Abbott Healthcare、Abbvie Inc.、Brsitol-Myers Squibb、Janssen Therapeutics、Gilead Sciences、Merck & Co. Inc、VIIV Healthcare、BD Biosciences、Beckman Coulter、Partec、Sysmex、Apogee Flow Systems、PointCare Technologies Inc.、Zyomyx Inc.、Mylan inc.、Roche Diagnostics、Siemens Healthcare、Qiagen、BioMerieux ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The HIV diagnostics market encompasses diagnostic screening and confirmatory tests for HIV-1, 2 and group O incidence testing. These tests have primary applications to screen and differentiate between the various groups and subtypes of human immunodeficiency virus.
Owing to the technological development of disease diagnostic tests and the anticipated development and commercialization of novel, regulatory authorities approved POC and rapid CD4, p24 antigen and EID tests, it is expected that all the major regional market segments will witness an increase in market demand over the forecast period.
Market Analysis and Insights: Global HIV Diagnostics Market
The global HIV Diagnostics market size is projected to reach US$ 2878.6 million by 2026, from US$ 2636.2 million in 2020, at a CAGR of 8.5%% during 2021-2026.
Global HIV Diagnostics Scope and Market Size
HIV Diagnostics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global HIV Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Abbott Healthcare
Abbvie Inc.
Brsitol-Myers Squibb
Janssen Therapeutics
Gilead Sciences
Merck & Co. Inc
VIIV Healthcare
BD Biosciences
Beckman Coulter
Partec
Sysmex
Apogee Flow Systems
PointCare Technologies Inc.
Zyomyx Inc.
Mylan inc.
Roche Diagnostics
Siemens Healthcare
Qiagen
BioMerieux
Market segment by Type, the product can be split into
Consumables
Assay, Kits and Reagents
Other Consumables
Instruments
Software and Services
Market segment by Application, split into
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by HIV Diagnostics Revenue
1.4 Market by Type
1.4.1 Global HIV Diagnostics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Consumables
1.4.3 Assay, Kits and Reagents
1.4.4 Other Consumables
1.4.5 Instruments
1.4.6 Software and Services
1.5 Market by Application
1.5.1 Global HIV Diagnostics Market Share by Application: 2020 VS 2026
1.5.2 Antibody Tests
1.5.3 Viral Load Tests
1.5.4 CD4 Tests
1.5.5 Tests for Early Infant Diagnosis
1.5.6 Tests for Viral Identification
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global HIV Diagnostics Market Perspective (2015-2026)
2.2 Global HIV Diagnostics Growth Trends by Regions
2.2.1 HIV Diagnostics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 HIV Diagnostics Historic Market Share by Regions (2015-2020)
2.2.3 HIV Diagnostics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 HIV Diagnostics Market Growth Strategy
2.3.6 Primary Interviews with Key HIV Diagnostics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top HIV Diagnostics Players by Market Size
3.1.1 Global Top HIV Diagnostics Players by Revenue (2015-2020)
3.1.2 Global HIV Diagnostics Revenue Market Share by Players (2015-2020)
3.1.3 Global HIV Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global HIV Diagnostics Market Concentration Ratio
3.2.1 Global HIV Diagnostics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by HIV Diagnostics Revenue in 2019
3.3 HIV Diagnostics Key Players Head office and Area Served
3.4 Key Players HIV Diagnostics Product Solution and Service
3.5 Date of Enter into HIV Diagnostics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global HIV Diagnostics Historic Market Size by Type (2015-2020)
4.2 Global HIV Diagnostics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global HIV Diagnostics Market Size by Application (2015-2020)
5.2 Global HIV Diagnostics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America HIV Diagnostics Market Size (2015-2020)
6.2 HIV Diagnostics Key Players in North America (2019-2020)
6.3 North America HIV Diagnostics Market Size by Type (2015-2020)
6.4 North America HIV Diagnostics Market Size by Application (2015-2020)
7 Europe
7.1 Europe HIV Diagnostics Market Size (2015-2020)
7.2 HIV Diagnostics Key Players in Europe (2019-2020)
7.3 Europe HIV Diagnostics Market Size by Type (2015-2020)
7.4 Europe HIV Diagnostics Market Size by Application (2015-2020)
8 China
8.1 China HIV Diagnostics Market Size (2015-2020)
8.2 HIV Diagnostics Key Players in China (2019-2020)
8.3 China HIV Diagnostics Market Size by Type (2015-2020)
8.4 China HIV Diagnostics Market Size by Application (2015-2020)
9 Japan
9.1 Japan HIV Diagnostics Market Size (2015-2020)
9.2 HIV Diagnostics Key Players in Japan (2019-2020)
9.3 Japan HIV Diagnostics Market Size by Type (2015-2020)
9.4 Japan HIV Diagnostics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia HIV Diagnostics Market Size (2015-2020)
10.2 HIV Diagnostics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia HIV Diagnostics Market Size by Type (2015-2020)
10.4 Southeast Asia HIV Diagnostics Market Size by Application (2015-2020)
11 India
11.1 India HIV Diagnostics Market Size (2015-2020)
11.2 HIV Diagnostics Key Players in India (2019-2020)
11.3 India HIV Diagnostics Market Size by Type (2015-2020)
11.4 India HIV Diagnostics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America HIV Diagnostics Market Size (2015-2020)
12.2 HIV Diagnostics Key Players in Central & South America (2019-2020)
12.3 Central & South America HIV Diagnostics Market Size by Type (2015-2020)
12.4 Central & South America HIV Diagnostics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott HIV Diagnostics Introduction
13.1.4 Abbott Revenue in HIV Diagnostics Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Abbott Healthcare
13.2.1 Abbott Healthcare Company Details
13.2.2 Abbott Healthcare Business Overview
13.2.3 Abbott Healthcare HIV Diagnostics Introduction
13.2.4 Abbott Healthcare Revenue in HIV Diagnostics Business (2015-2020)
13.2.5 Abbott Healthcare Recent Development
13.3 Abbvie Inc.
13.3.1 Abbvie Inc. Company Details
13.3.2 Abbvie Inc. Business Overview
13.3.3 Abbvie Inc. HIV Diagnostics Introduction
13.3.4 Abbvie Inc. Revenue in HIV Diagnostics Business (2015-2020)
13.3.5 Abbvie Inc. Recent Development
13.4 Brsitol-Myers Squibb
13.4.1 Brsitol-Myers Squibb Company Details
13.4.2 Brsitol-Myers Squibb Business Overview
13.4.3 Brsitol-Myers Squibb HIV Diagnostics Introduction
13.4.4 Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2015-2020)
13.4.5 Brsitol-Myers Squibb Recent Development
13.5 Janssen Therapeutics
13.5.1 Janssen Therapeutics Company Details
13.5.2 Janssen Therapeutics Business Overview
13.5.3 Janssen Therapeutics HIV Diagnostics Introduction
13.5.4 Janssen Therapeutics Revenue in HIV Diagnostics Business (2015-2020)
13.5.5 Janssen Therapeutics Recent Development
13.6 Gilead Sciences
13.6.1 Gilead Sciences Company Details
13.6.2 Gilead Sciences Business Overview
13.6.3 Gilead Sciences HIV Diagnostics Introduction
13.6.4 Gilead Sciences Revenue in HIV Diagnostics Business (2015-2020)
13.6.5 Gilead Sciences Recent Development
13.7 Merck & Co. Inc
13.7.1 Merck & Co. Inc Company Details
13.7.2 Merck & Co. Inc Business Overview
13.7.3 Merck & Co. Inc HIV Diagnostics Introduction
13.7.4 Merck & Co. Inc Revenue in HIV Diagnostics Business (2015-2020)
13.7.5 Merck & Co. Inc Recent Development
13.8 VIIV Healthcare
13.8.1 VIIV Healthcare Company Details
13.8.2 VIIV Healthcare Business Overview
13.8.3 VIIV Healthcare HIV Diagnostics Introduction
13.8.4 VIIV Healthcare Revenue in HIV Diagnostics Business (2015-2020)
13.8.5 VIIV Healthcare Recent Development
13.9 BD Biosciences
13.9.1 BD Biosciences Company Details
13.9.2 BD Biosciences Business Overview
13.9.3 BD Biosciences HIV Diagnostics Introduction
13.9.4 BD Biosciences Revenue in HIV Diagnostics Business (2015-2020)
13.9.5 BD Biosciences Recent Development
13.10 Beckman Coulter
13.10.1 Beckman Coulter Company Details
13.10.2 Beckman Coulter Business Overview
13.10.3 Beckman Coulter HIV Diagnostics Introduction
13.10.4 Beckman Coulter Revenue in HIV Diagnostics Business (2015-2020)
13.10.5 Beckman Coulter Recent Development
13.11 Partec
10.11.1 Partec Company Details
10.11.2 Partec Business Overview
10.11.3 Partec HIV Diagnostics Introduction
10.11.4 Partec Revenue in HIV Diagnostics Business (2015-2020)
10.11.5 Partec Recent Development
13.12 Sysmex
10.12.1 Sysmex Company Details
10.12.2 Sysmex Business Overview
10.12.3 Sysmex HIV Diagnostics Introduction
10.12.4 Sysmex Revenue in HIV Diagnostics Business (2015-2020)
10.12.5 Sysmex Recent Development
13.13 Apogee Flow Systems
10.13.1 Apogee Flow Systems Company Details
10.13.2 Apogee Flow Systems Business Overview
10.13.3 Apogee Flow Systems HIV Diagnostics Introduction
10.13.4 Apogee Flow Systems Revenue in HIV Diagnostics Business (2015-2020)
10.13.5 Apogee Flow Systems Recent Development
13.14 PointCare Technologies Inc.
10.14.1 PointCare Technologies Inc. Company Details
10.14.2 PointCare Technologies Inc. Business Overview
10.14.3 PointCare Technologies Inc. HIV Diagnostics Introduction
10.14.4 PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2015-2020)
10.14.5 PointCare Technologies Inc. Recent Development
13.15 Zyomyx Inc.
10.15.1 Zyomyx Inc. Company Details
10.15.2 Zyomyx Inc. Business Overview
10.15.3 Zyomyx Inc. HIV Diagnostics Introduction
10.15.4 Zyomyx Inc. Revenue in HIV Diagnostics Business (2015-2020)
10.15.5 Zyomyx Inc. Recent Development
13.16 Mylan inc.
10.16.1 Mylan inc. Company Details
10.16.2 Mylan inc. Business Overview
10.16.3 Mylan inc. HIV Diagnostics Introduction
10.16.4 Mylan inc. Revenue in HIV Diagnostics Business (2015-2020)
10.16.5 Mylan inc. Recent Development
13.17 Roche Diagnostics
10.17.1 Roche Diagnostics Company Details
10.17.2 Roche Diagnostics Business Overview
10.17.3 Roche Diagnostics HIV Diagnostics Introduction
10.17.4 Roche Diagnostics Revenue in HIV Diagnostics Business (2015-2020)
10.17.5 Roche Diagnostics Recent Development
13.18 Siemens Healthcare
10.18.1 Siemens Healthcare Company Details
10.18.2 Siemens Healthcare Business Overview
10.18.3 Siemens Healthcare HIV Diagnostics Introduction
10.18.4 Siemens Healthcare Revenue in HIV Diagnostics Business (2015-2020)
10.18.5 Siemens Healthcare Recent Development
13.19 Qiagen
10.19.1 Qiagen Company Details
10.19.2 Qiagen Business Overview
10.19.3 Qiagen HIV Diagnostics Introduction
10.19.4 Qiagen Revenue in HIV Diagnostics Business (2015-2020)
10.19.5 Qiagen Recent Development
13.20 BioMerieux
10.20.1 BioMerieux Company Details
10.20.2 BioMerieux Business Overview
10.20.3 BioMerieux HIV Diagnostics Introduction
10.20.4 BioMerieux Revenue in HIV Diagnostics Business (2015-2020)
10.20.5 BioMerieux Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. HIV Diagnostics Key Market Segments
Table 2. Key Players Covered: Ranking by HIV Diagnostics Revenue
Table 3. Ranking of Global Top HIV Diagnostics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global HIV Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Consumables
Table 6. Key Players of Assay, Kits and Reagents
Table 7. Key Players of Other Consumables
Table 8. Key Players of Instruments
Table 9. Key Players of Software and Services
Table 10. Global HIV Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global HIV Diagnostics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global HIV Diagnostics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global HIV Diagnostics Market Share by Regions (2015-2020)
Table 14. Global HIV Diagnostics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global HIV Diagnostics Market Share by Regions (2021-2026)
Table 16. Market Top Trends
Table 17. Key Drivers: Impact Analysis
Table 18. Key Challenges
Table 19. HIV Diagnostics Market Growth Strategy
Table 20. Main Points Interviewed from Key HIV Diagnostics Players
Table 21. Global HIV Diagnostics Revenue by Players (2015-2020) (Million US$)
Table 22. Global HIV Diagnostics Market Share by Players (2015-2020)
Table 23. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Diagnostics as of 2019)
Table 24. Global HIV Diagnostics by Players Market Concentration Ratio (CR5 and HHI)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players HIV Diagnostics Product Solution and Service
Table 27. Date of Enter into HIV Diagnostics Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global HIV Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 30. Global HIV Diagnostics Market Size Share by Type (2015-2020)
Table 31. Global HIV Diagnostics Revenue Market Share by Type (2021-2026)
Table 32. Global HIV Diagnostics Market Size Share by Application (2015-2020)
Table 33. Global HIV Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 34. Global HIV Diagnostics Market Size Share by Application (2021-2026)
Table 35. North America Key Players HIV Diagnostics Revenue (2019-2020) (Million US$)
Table 36. North America Key Players HIV Diagnostics Market Share (2019-2020)
Table 37. North America HIV Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 38. North America HIV Diagnostics Market Share by Type (2015-2020)
Table 39. North America HIV Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 40. North America HIV Diagnostics Market Share by Application (2015-2020)
Table 41. Europe Key Players HIV Diagnostics Revenue (2019-2020) (Million US$)
Table 42. Europe Key Players HIV Diagnostics Market Share (2019-2020)
Table 43. Europe HIV Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 44. Europe HIV Diagnostics Market Share by Type (2015-2020)
Table 45. Europe HIV Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 46. Europe HIV Diagnostics Market Share by Application (2015-2020)
Table 47. China Key Players HIV Diagnostics Revenue (2019-2020) (Million US$)
Table 48. China Key Players HIV Diagnostics Market Share (2019-2020)
Table 49. China HIV Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 50. China HIV Diagnostics Market Share by Type (2015-2020)
Table 51. China HIV Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 52. China HIV Diagnostics Market Share by Application (2015-2020)
Table 53. Japan Key Players HIV Diagnostics Revenue (2019-2020) (Million US$)
Table 54. Japan Key Players HIV Diagnostics Market Share (2019-2020)
Table 55. Japan HIV Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 56. Japan HIV Diagnostics Market Share by Type (2015-2020)
Table 57. Japan HIV Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 58. Japan HIV Diagnostics Market Share by Application (2015-2020)
Table 59. Southeast Asia Key Players HIV Diagnostics Revenue (2019-2020) (Million US$)
Table 60. Southeast Asia Key Players HIV Diagnostics Market Share (2019-2020)
Table 61. Southeast Asia HIV Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 62. Southeast Asia HIV Diagnostics Market Share by Type (2015-2020)
Table 63. Southeast Asia HIV Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 64. Southeast Asia HIV Diagnostics Market Share by Application (2015-2020)
Table 65. India Key Players HIV Diagnostics Revenue (2019-2020) (Million US$)
Table 66. India Key Players HIV Diagnostics Market Share (2019-2020)
Table 67. India HIV Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 68. India HIV Diagnostics Market Share by Type (2015-2020)
Table 69. India HIV Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 70. India HIV Diagnostics Market Share by Application (2015-2020)
Table 71. Central & South America Key Players HIV Diagnostics Revenue (2019-2020) (Million US$)
Table 72. Central & South America Key Players HIV Diagnostics Market Share (2019-2020)
Table 73. Central & South America HIV Diagnostics Market Size by Type (2015-2020) (Million US$)
Table 74. Central & South America HIV Diagnostics Market Share by Type (2015-2020)
Table 75. Central & South America HIV Diagnostics Market Size by Application (2015-2020) (Million US$)
Table 76. Central & South America HIV Diagnostics Market Share by Application (2015-2020)
Table 77. Abbott Company Details
Table 78. Abbott Business Overview
Table 79. Abbott Product
Table 80. Abbott Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 81. Abbott Recent Development
Table 82. Abbott Healthcare Company Details
Table 83. Abbott Healthcare Business Overview
Table 84. Abbott Healthcare Product
Table 85. Abbott Healthcare Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 86. Abbott Healthcare Recent Development
Table 87. Abbvie Inc. Company Details
Table 88. Abbvie Inc. Business Overview
Table 89. Abbvie Inc. Product
Table 90. Abbvie Inc. Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 91. Abbvie Inc. Recent Development
Table 92. Brsitol-Myers Squibb Company Details
Table 93. Brsitol-Myers Squibb Business Overview
Table 94. Brsitol-Myers Squibb Product
Table 95. Brsitol-Myers Squibb Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 96. Brsitol-Myers Squibb Recent Development
Table 97. Janssen Therapeutics Company Details
Table 98. Janssen Therapeutics Business Overview
Table 99. Janssen Therapeutics Product
Table 100. Janssen Therapeutics Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 101. Janssen Therapeutics Recent Development
Table 102. Gilead Sciences Company Details
Table 103. Gilead Sciences Business Overview
Table 104. Gilead Sciences Product
Table 105. Gilead Sciences Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 106. Gilead Sciences Recent Development
Table 107. Merck & Co. Inc Company Details
Table 108. Merck & Co. Inc Business Overview
Table 109. Merck & Co. Inc Product
Table 110. Merck & Co. Inc Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 111. Merck & Co. Inc Recent Development
Table 112. VIIV Healthcare Business Overview
Table 113. VIIV Healthcare Product
Table 114. VIIV Healthcare Company Details
Table 115. VIIV Healthcare Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 116. VIIV Healthcare Recent Development
Table 117. BD Biosciences Company Details
Table 118. BD Biosciences Business Overview
Table 119. BD Biosciences Product
Table 120. BD Biosciences Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 121. BD Biosciences Recent Development
Table 122. Beckman Coulter Company Details
Table 123. Beckman Coulter Business Overview
Table 124. Beckman Coulter Product
Table 125. Beckman Coulter Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 126. Beckman Coulter Recent Development
Table 127. Partec Company Details
Table 128. Partec Business Overview
Table 129. Partec Product
Table 130. Partec Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 131. Partec Recent Development
Table 132. Sysmex Company Details
Table 133. Sysmex Business Overview
Table 134. Sysmex Product
Table 135. Sysmex Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 136. Sysmex Recent Development
Table 137. Apogee Flow Systems Company Details
Table 138. Apogee Flow Systems Business Overview
Table 139. Apogee Flow Systems Product
Table 140. Apogee Flow Systems Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 141. Apogee Flow Systems Recent Development
Table 142. PointCare Technologies Inc. Company Details
Table 143. PointCare Technologies Inc. Business Overview
Table 144. PointCare Technologies Inc. Product
Table 145. PointCare Technologies Inc. Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 146. PointCare Technologies Inc. Recent Development
Table 147. Zyomyx Inc. Company Details
Table 148. Zyomyx Inc. Business Overview
Table 149. Zyomyx Inc. Product
Table 150. Zyomyx Inc. Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 151. Zyomyx Inc. Recent Development
Table 152. Mylan inc. Company Details
Table 153. Mylan inc. Business Overview
Table 154. Mylan inc. Product
Table 155. Mylan inc. Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 156. Mylan inc. Recent Development
Table 157. Roche Diagnostics Company Details
Table 158. Roche Diagnostics Business Overview
Table 159. Roche Diagnostics Product
Table 160. Roche Diagnostics Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 161. Roche Diagnostics Recent Development
Table 162. Siemens Healthcare Company Details
Table 163. Siemens Healthcare Business Overview
Table 164. Siemens Healthcare Product
Table 165. Siemens Healthcare Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 166. Siemens Healthcare Recent Development
Table 167. Qiagen Company Details
Table 168. Qiagen Business Overview
Table 169. Qiagen Product
Table 170. Qiagen Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 171. Qiagen Recent Development
Table 172. BioMerieux Company Details
Table 173. BioMerieux Business Overview
Table 174. BioMerieux Product
Table 175. BioMerieux Revenue in HIV Diagnostics Business (2015-2020) (Million US$)
Table 176. BioMerieux Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Global HIV Diagnostics Market Share by Type: 2020 VS 2026
Figure 2. Consumables Features
Figure 3. Assay, Kits and Reagents Features
Figure 4. Other Consumables Features
Figure 5. Instruments Features
Figure 6. Software and Services Features
Figure 7. Global HIV Diagnostics Market Share by Application: 2020 VS 2026
Figure 8. Antibody Tests Case Studies
Figure 9. Viral Load Tests Case Studies
Figure 10. CD4 Tests Case Studies
Figure 11. Tests for Early Infant Diagnosis Case Studies
Figure 12. Tests for Viral Identification Case Studies
Figure 13. HIV Diagnostics Report Years Considered
Figure 14. Global HIV Diagnostics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global HIV Diagnostics Market Share by Regions: 2020 VS 2026
Figure 16. Global HIV Diagnostics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global HIV Diagnostics Market Share by Players in 2019
Figure 19. Global Top HIV Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in HIV Diagnostics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by HIV Diagnostics Revenue in 2019
Figure 21. North America HIV Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe HIV Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China HIV Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan HIV Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia HIV Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India HIV Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America HIV Diagnostics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
自己免疫疾患用体外診断（IVD）・ラボ開発検査の世界市場（～2026年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…- E型肝炎診断検査の世界市場（～2026年） Hepatitis E is a virus that affects your liver. Market Analysis and Insights: Global Hepatitis E Diagnostic Tests Market The global Hepatitis E Diagnostic Tests market size is projected to reach US$ 43 million by 2026, from US$ 42 million in 2020, at a CAGR of 2.2%% during 2021-2026. Global Hepatiti…
- ウイルス性肝炎・レトロウイルス診断検査の世界市場（～2026年） Diagnostics tests for viral hepatitis and retrovirus help in screening, diagnosing, and managing diseases in humans. The tests are usually performed in the laboratory under controlled environment. In hepatitis and retrovirus infections, the diagnostic tests provide a valuable health status of patien…
- 補体欠損症検査の世界市場（～2026年） Complement is the group of serum glycoprotein, the part of innate immune system that enhances the ability of antibodies and macrophages to clear the damaged cells and pathogens. Complement also promotes inflammation and aids in enhancing the immune response. The complement system is activated throug…
- 甲状腺機能検査の世界市場（～2026年） Thyroid Function Tests (TFT) include various blood tests which are conducted to identify the functions of thyroid gland. The rise in prevalence of thyroid diseases is estimated to be one of the primary growth factors for the thyroid functioning tests market. The excess or deficiency of thyroid hormo…